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cancer. The mRNA level of AKAP12α gene was examined by reverse 
transcription-polymerase chain reaction (RT-PCR) in ten lung cancer 
cell lines. The mRNA level of AKAP12α gene was reduced in 6 of 10 
(60%) lung cancer cell lines. The AKAP12α expression was restored 
after treatment with the demethylating agent 5-aza-2’-deoxycytidine 
in lung cancer cell lines which have downregulated mRNA level of 
AKAP12α gene. This result was further substantiated by a luciferase 
reporter assay, showing the restoration of promoter activities when 
transfected with unmethylated AKAP12α promoter. The methyla-
tion status of CpG island 1 and 2 existed in the AKAP12α promoter 
was analyzed by performing bisulﬁte-sequencing analysis in ten lung 
cancer cell lines, forty six lung cancer tissues and matched normal 
tissues. Methylation of CpG island 1 in the AKAP12α promoter was 
detected in 30% of the lung cancer cell lines, whereas methylation of 
CpG island 2 in the AKAP12α promoter was observed in the immor-
talized bronchial cell line and in all the lung cancer cell lines. In all 
of the lung tumors, the CpG island 1 in the AKAP12α promoter was 
infrequently methylated. However, CpG island 2 in the AKAP12α 
promoter was highly methylated in lung tumors compared with the sur-
rounding normal tissues, and this was statistically signiﬁcant (p=0.002). 
Also, the analysis in the methylation level of CpG island 2 and the 
patient’s clinicopathological features was showed that the CpG island 2 
methylation of AKAP12α gene in male, non-recurrence subgroup was 
occurred more frequently than other subgroup. In summary, epigenetic 
AKAP12α silencing seems to be a relevant mechanism of inactivat-
ing this AKAP12α gene in lung cancer and the methylation rate of 
AKAP12α promoter is associated with lung cancer.
This study was supported by a grant of the Ministry of Health & Wel-
fare, Republic of Korea: A010250
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Introduction: Researches of cancer have two ways, in vivo and in vitro. 
Most of them are in vitro and their results are promising. However, us-
ing their results to in vivo had been disappointed because tumor contains 
3 dimensional structure, complicated components, and intercellular 
and/or cell/matrix interactions. Multicellular tumor spheroids (MCTS) 
is a kind of new research area of biology but lack of stromal cells and 
tumor associated macrophages. Artiﬁcial organisms, which have similar 
cell components compare with tumor, will be more complicated and 
advanced model than MCTS. We tried making a multicomponent mul-
ticellular tumor spheroids (MMCTS) from 3 kinds of cells from cancer 
cell from cancer cell line, ﬁbroblasts and peripheral blood mononuclear 
cells(PBMC) from human as a models to cancer research.
Method: A549 cell line, ﬁbroblasts cultured from human, and PBMC 
were cultured on rotatory cell culture system (RCCS) singly or com-
bined in DME media. Their formation of spheroids were observed 2 
times a week by inverted microscope and got samples serially for 4 
weeks. Cell components from combined spheroids were stained immu-
nohistochemically by antibody to cytokeratin, ﬁbroblast and CD68. 
Result: Cells, cultured singly, were aggregated and formed clusters 
except PBMC within a few days and formed spheroids between 4 to 
7 days. Fibroblasts were formed earlier than A549. The mixed cluster 
with A549, ﬁbroblast and PBMC were also formed round shape. Immu-
nohistochemical stain showed that cells from MMCTS preserved their 
characteristics for 4 weeks. 
Conclusion: MMCTS will be a new model for tumor research.
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Design: We investigated histopathological differentiation-associated 
proteins (HD proteins) of non-small cell lung cancer (NSCLC) using 2 
dimensional polyacrylamide gel electrophoresis (2DE) and attempted 
to classify NSCLC. We applied Ettan-DIGE system to 2DE analysis 
and investigated HD proteins on a single 2DE gel to compensate for the 
unfavorable reproducibility of 2DE analysis.
Materials and Methods: We collected samples for 2-DE from repre-
sentative histological types of primary lung cancer, such as squamous 
cell carcinoma, adenocarcinoma and small cell carcinoma between 
2003 and 2005. We selected 8 cases of well or moderately differenti-
ated squamous cell carcinoma conﬁrmed postoperativly to posses 
typical histological features of primary lung squamous cell carcinoma. 
The mixture that contained equal amount of these eight samples was 
regarded as a standard sample of lung squamous cell carcinoma (Sq 
standard sample). In the same way we selected 8 cases of well or mod-
erately differentiated adenocarcinoma to prefers a standard sample of 
primary lung adenocarcinoma (Ad standard sample). We also mixed all 
four cases of small cell carcinoma samples which were collected during 
these periods, and preferred a mixture as a standard sample of small 
cell carcinoma (Sm standard sample). Each standard sample of repre-
sentative histopathological types of primary lung cancer was labeled 
with 400 pmol of a ﬂuorescent dye (either Cy2, Cy3 or Cy5) per 50 µg 
protein according to the manufacturer’s protocol (GE Healthcare Bi-
osicences). Furthermore, using mass spectrometry we identiﬁed protein 
molecules that were detected in 2DE analysis, followed by validation 
analysis by immunohistochemistry.
Results: We detected 7 spots associated with squamous cell carci-
noma, 9 spots associated with adenocarcinoma and 13 spots associated 
with neuroendocrine carcinoma (NE-associated spots) on 2DE gel, 
and succeeded in identifying all histopathological associated proteins 
except three NE-associated proteins (Figure 1, Table 2). Of 29 identi-
ﬁed proteins in this investigation 8 were cytokeratin (CK), which were 
CK5, CK6A, CK8, CK6C, CK6D, CK17, CK18 and CK19. CK5, 
CK6A, CK6C, CK6D and CK17 were identiﬁed as a Sq-associated pro-
tein, and also CK8, CK18 and CK19 were identiﬁed as Ad-associated 
protein. The other identiﬁed proteins we recognized contained napsin 
A and annexin A4. We tried to validate the expression of various kinds 
of CK using immunohistochemical analysis. In CK5, CK5/6 and CK17 
the expression levels in squamous cell carcinoma were greater than in 
the other histopathological types. On the other hand, the expression 
levels of CK8 and CK18 in adenocarcinoma were greater than the other 
